Evaluation of thrombophylic states in myeloma patients receiving thalidomide: a reasonable doubt.
Santos
Ana Belén
AB
Llamas
Pilar
P
Román
Alejandro
A
Prieto
Elena
E
De Oña
Raquel
R
De Velasco
Jaime Fernández
JF
Tomás
José Francisco
JF
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects*; D020246:Venous Thrombosis / Q000139:chemically induced*
D020533:Angiogenesis Inhibitors; D013792:Thalidomide